Integer Holdings Corp
Business
Integer Holdings Corporation is a medical device contract development and manufacturing organization (CDMO) serving cardio and vascular, neuromodulation, and cardiac rhythm management markets. It provides components, subassemblies, and finished devices through brands including Greatbatch Medical and Lake Region Medical. The company operates through three principal product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets, with manufacturing facilities across the U.S., Mexico, Uruguay, Ireland, Malaysia, Costa Rica, and the Dominican Republic.
Summary from 10-K filed 2026-02-23
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1,854 | 1,717 | 1,556 | 1,331 | 1,221 | |
| Cost of sales | 1,353 | 1,258 | 1,146 | 986 | 884 | |
| Gross profit | 500 | 459 | 410 | 346 | 337 | |
| Selling, general and administrative | 212 | 185 | 173 | 158 | 141 | |
| Research, development and engineering | 49 | 53 | 62 | 60 | 52 | |
| Restructuring and other charges | 18 | 12 | 11 | 15 | 8 | |
| Total operating expenses | 279 | 251 | 247 | 233 | 201 | |
| Operating income | 221 | 208 | 163 | 113 | 136 | |
| Interest expense | 43 | 56 | 51 | 37 | — | |
| (Gain) loss on equity investments, net | −550,000 | 780,000 | 6 | 8 | 3 | |
| Other loss, net | 53 | 4 | 975,000 | −899,000 | −123,000 | |
| Income from continuing operations before income taxes | 125 | 148 | 105 | 69 | 101 | |
| Provision for income taxes | 23 | 27 | 16 | 9 | 8 | |
| Income from continuing operations | 103 | 121 | 89 | 60 | 93 | |
| Income (loss) from discontinued operations, net of tax | −22,000 | −1 | 2 | 7 | 4 | |
| Net income | 103 | 120 | 91 | 66 | 97 | |
| Income from continuing operations (in dollars per share) | 2.96 | 3.6 | 2.68 | 1.8 | 2.82 | |
| Income from discontinued operations (in dollars per share) | 0 | −0.03 | 0.05 | 0.2 | 0.11 | |
| Basic earnings per share (in dollars per share) | 2.96 | 3.57 | 2.72 | 2 | 2.93 | |
| Income from continuing operations (in dollars per share) | 2.89 | 3.4 | 2.64 | 1.79 | 2.8 | |
| Income (loss) from discontinued operations (in dollars per share) | 0 | −0.03 | 0.04 | 0.2 | 0.11 | |
| Diluted earnings per share (in dollars per share) | 2.89 | 3.36 | 2.69 | 1.99 | 2.91 | |
| Basic (in shares) | 35 | 34 | 33 | 33 | 33 | |
| Diluted (in shares) | 36 | 36 | 34 | 33 | 33 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 17 | 47 | 24 | 24 | — | |
| Accounts receivable, net of provision for credit losses of $0.6 million and $0.3 million, respectively | 346 | 245 | 231 | 224 | 182 | |
| Inventories | 254 | 247 | 229 | 209 | 156 | |
| Contract assets | 113 | 104 | 86 | 72 | 65 | |
| Prepaid expenses and other current assets | 41 | 28 | 30 | 27 | 28 | |
| Total current assets | 770 | 671 | 618 | 558 | 453 | |
| Property, plant and equipment, net | 536 | 466 | 393 | 317 | 277 | |
| Goodwill | 1,111 | 1,018 | 994 | 965 | 925 | |
| Other intangible assets, net | 825 | 778 | 780 | 820 | 808 | |
| Deferred income taxes | 9 | 8 | 7 | 6 | 6 | |
| Operating lease assets | 98 | 86 | 81 | 75 | 70 | |
| Financing lease assets | 37 | 28 | 12 | 9 | 8 | |
| Other long-term assets | 23 | 23 | 22 | 27 | 36 | |
| Total assets | 3,411 | 3,078 | 2,943 | 2,794 | 2,582 | |
| Current portion of long-term debt | 0 | 10 | 0 | 18 | 15 | |
| Accounts payable | 113 | 101 | 118 | 111 | 77 | |
| Operating lease liabilities | 9 | 7 | 9 | 10 | 10 | |
| Accrued expenses and other current liabilities | 110 | 108 | 91 | 73 | 57 | |
| Total current liabilities | 232 | 227 | 221 | 224 | 160 | |
| Long-term debt | 1,185 | 980 | 960 | 907 | 813 | |
| Deferred income taxes | 116 | 125 | 144 | 161 | 172 | |
| Operating lease liabilities | 82 | 78 | 72 | 64 | 60 | |
| Financing lease liabilities | 29 | 24 | 10 | 8 | 7 | |
| Other long-term liabilities | 20 | 25 | 14 | 13 | 16 | |
| Total liabilities | 1,664 | 1,459 | 1,424 | 1,377 | 1,228 | |
| Commitments and contingencies (Note 14) | — | — | — | — | — | |
| Preferred stock, $0.001 par value, authorized 100,000,000 shares; no shares issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.001 par value; 100,000,000 shares authorized; 35,481,805 and 33,546,262 shares issued, respectively, and 34,346,450 and 33,546,256 outstanding, respectively | 35,000 | 34,000 | 33,000 | 33,000 | 33,000 | |
| Additional paid-in capital | 771 | 742 | 727 | 731 | 713 | |
| Treasury stock, at cost, 1,135,355 shares and 6 shares, respectively | −77 | 0 | 0 | — | — | |
| Retained earnings | 994 | 891 | 771 | 681 | 614 | |
| Accumulated other comprehensive income (loss) | 58 | −14 | 20 | 5 | 27 | |
| Total stockholders equity | 1,747 | 1,619 | 1,519 | 1,417 | 1,355 | |
| Total liabilities and stockholders equity | 3,411 | 3,078 | 2,943 | 2,794 | 2,582 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 131 | 111 | 99 | 92 | 81 | |
| Debt related charges included in interest expense | 7 | 4 | 8 | 2 | 7 | |
| Debt conversion inducement expense | 47 | 0 | 0 | — | — | |
| Inventory step-up amortization | 0 | 1 | 590,000 | 798,000 | 301,000 | |
| Stock-based compensation | 23 | 25 | 23 | 21 | 16 | |
| Non-cash lease expense | 10 | 9 | 11 | 11 | 8 | |
| Non-cash (gain) loss on equity investments | −550,000 | 780,000 | 6 | 8 | 3 | |
| Contingent consideration fair value adjustment | −2 | −4 | −736,000 | 3 | 133,000 | |
| Other non-cash losses | 2 | 7 | 4 | 6 | 2 | |
| Deferred income taxes | −3 | −14 | −9 | −17 | −10 | |
| Gain on sale of discontinued operations | −46,000 | −177,000 | 0 | 0 | 0 | |
| Accounts receivable | −82 | −7 | −7 | −41 | −18 | |
| Inventories | −3 | −18 | −30 | −57 | 5 | |
| Contract assets | −7 | −18 | −14 | −8 | −25 | |
| Prepaid expenses and other assets | −2 | −229,000 | −930,000 | 764,000 | −2 | |
| Accounts payable | −566,000 | −17 | −520,000 | 26 | 20 | |
| Accrued expenses and other liabilities | −20 | 4 | 8 | −10 | −23 | |
| Income taxes payable | −5 | 811,000 | −7 | 13 | −4 | |
| Net cash provided by operating activities | 196 | 205 | 180 | 116 | 157 | |
| Acquisition of property, plant and equipment | −91 | −105 | −120 | −75 | −53 | |
| Acquisitions, net of cash acquired | −179 | −139 | −44 | −127 | −218 | |
| Proceeds (settlement of working capital) from sale of discontinued operations, net | −950,000 | 49 | 0 | 0 | — | |
| Other investing activities | 123,000 | −211,000 | 173,000 | — | — | |
| Net cash used in investing activities | −271 | −195 | −163 | −200 | −271 | |
| Principal payments of long-term debt | −668 | −6,000 | −416 | — | — | |
| Proceeds from issuance of convertible notes, net of discount | 978 | 0 | 486 | 0 | 818 | |
| Proceeds from revolving credit facility | 307 | 275 | 383 | 166 | 82 | |
| Payments of revolving credit facility | −433 | −248 | −425 | −45 | −63 | |
| Purchase of capped calls | −71 | 0 | −35 | 0 | 0 | |
| Payment of debt issuance costs | −1 | −2 | −2 | 0 | −8 | |
| Repurchases of common stock | −50 | 0 | 0 | — | — | |
| Proceeds from the exercise of stock options | 4 | 742,000 | 2 | 150,000 | 743,000 | |
| Tax withholdings related to net share settlements of restricted stock units | −17 | −11 | −3 | −3 | −5 | |
| Payment of contingent consideration | 0 | 0 | −8 | −972,000 | −2 | |
| Principal payments on finance leases | −6 | −11 | −1 | −843,000 | −169,000 | |
| Other financing activities | 1 | 9 | 190,000 | 0 | — | |
| Net cash provided by (used in) financing activities | 44 | 13 | −18 | 92 | 82 | |
| Effect of foreign currency exchange rates on cash and cash equivalents | 2 | −243,000 | 570,000 | −2 | 1 | |
| Net increase (decrease) in cash and cash equivalents | −29 | 23 | −598,000 | 6 | −31 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Integer Holdings Corp's CIK number?
Integer Holdings Corp's SEC CIK number is 0001114483 (1114483). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Integer Holdings Corp's SEC filings?
All of Integer Holdings Corp's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Integer Holdings Corp last report earnings?
Integer Holdings Corp (ITGR) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001171843-26-002878). This is Integer Holdings Corp's most recent earnings filing of record — not a forecast of its next earnings date.
What is Integer Holdings Corp's most recent earnings 8-K?
Integer Holdings Corp's latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0001171843-26-002878. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Integer Holdings Corp's latest earnings 8-K →
Look up any company's CIK number →